Kezar Life Sciences, Inc.
Hedge Funds Holdings
Last updated:
Kezar Life Sciences, Inc.‘s stocks are currently a part of 116 hedge funds’ portfolios, which represents 82.62% of the total amount of its stocks outstanding. This makes up a total of 43.58M shares of Kezar Life Sciences, Inc.. Compared to the previous quarter, the number grew by 8.20% or 3.30M shares more. As for the holding position changes, 38.79% (45) of current hedge fund investors increased the number of shares held, 33.62% (39) of current holders sold a part of the shares held, and 10.34% (12) closed the holdings completely. 23 hedge funds are new holders of Kezar Life Sciences, Inc. stock in Q1 2022, it is 19.83% of total holders.
Hedge funds holding Kezar Life Sciences (Q2 2018 – Q1 2022)
| Q2 2018 | 27 |
|---|---|
| Q3 2018 | 37 |
| Q4 2018 | 40 |
| Q1 2019 | 50 |
| Q2 2019 | 51 |
| Q3 2019 | 54 |
| Q4 2019 | 55 |
| Q1 2020 | 59 |
| Q2 2020 | 82 |
| Q3 2020 | 76 |
| Q4 2020 | 75 |
| Q1 2021 | 83 |
| Q2 2021 | 73 |
| Q3 2021 | 76 |
| Q4 2021 | 106 |
| Q1 2022 | 116 |
Hedge funds changes in Kezar Life Sciences positions (Q2 2018 – Q1 2022)
| Q2 2018 | 27 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 20 | 5 | 8 | 10 | -6 |
| Q4 2018 | 11 | 14 | 9 | 7 | -1 |
| Q1 2019 | 15 | 26 | 6 | 5 | -2 |
| Q2 2019 | 14 | 24 | 9 | 10 | -6 |
| Q3 2019 | 14 | 19 | 9 | 10 | 2 |
| Q4 2019 | 9 | 21 | 15 | 8 | 2 |
| Q1 2020 | 10 | 31 | 16 | 6 | -4 |
| Q2 2020 | 31 | 25 | 19 | 8 | -1 |
| Q3 2020 | 10 | 28 | 27 | 16 | -5 |
| Q4 2020 | 9 | 29 | 25 | 8 | 4 |
| Q1 2021 | 13 | 23 | 31 | 5 | 11 |
| Q2 2021 | 5 | 29 | 26 | 15 | -2 |
| Q3 2021 | 10 | 29 | 22 | 7 | 8 |
| Q4 2021 | 38 | 34 | 22 | 9 | 3 |
| Q1 2022 | 23 | 45 | 39 | 12 | -3 |
Hedge funds changes in Kezar Life Sciences stock options (Q2 2018 – Q1 2022)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 403,000 | 286,000 |
| Q3 2020 | 53,000 | 1,000 |
| Q4 2020 | 5,000 | 70,000 |
| Q1 2021 | 14,000 | 84,000 |
| Q2 2021 | 34,000 | 10,000 |
| Q3 2021 | 1,009,000 | 10,000 |
| Q4 2021 | 5,418,000 | 1,590,000 |
| Q1 2022 | 13,877,000 | 4,252,000 |